OncoLens
OncoLens is a tumor board software solution that replaces the manual and labor intensive process of collecting, presenting and reporting of cases for cancer conference.
5
Funding Rounds
$28.5m
Money raised
Overview
OncoLens is a tumor board software solution that replaces the manual and labor intensive process of collecting, presenting and reporting of cases for cancer conference.
-
Website:
- Business model: B2B
- Social accounts:
Funding
Funding series
Funding Series Analysis
The company OncoLens has raised a total of $19.85m in funding over 5 rounds.
Key Insights:
- OncoLens October 2024 Series B Funding Round: $16m
- OncoLens Seed round, January 2020: $2.5m
- OncoLens Seed round, March 2019: $1.35m
- OncoLens funding round, March 2019: $1.35m
- OncoLens Series A round January 2021: $7.3m
OncoLens October 2024 Series B Funding Round
$16m
OncoLens Seed round, January 2020
$2.5m
OncoLens Seed round, March 2019
$1.35m
OncoLens funding round, March 2019
$1.35m
OncoLens Series A round January 2021
$7.3m
Industries
OncoLens is active in the following industries: